Home Cart Sign in  
Chemical Structure| 19210-12-9 Chemical Structure| 19210-12-9

Structure of Harpagoside
CAS No.: 19210-12-9

Chemical Structure| 19210-12-9

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Harpagoside is a naturally occurring iridoid glycoside with anti-inflammatory effect.

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Harpagoside

CAS No. :19210-12-9
Formula : C24H30O11
M.W : 494.49
SMILES Code : O[C@@]1(C=CO2)[C@@]([C@@H]2O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)([H])[C@](OC(/C=C/C4=CC=CC=C4)=O)(C)C[C@H]1O
MDL No. :MFCD00017415
InChI Key :KVRQGMOSZKPBNS-FMHLWDFHSA-N
Pubchem ID :5281542

Safety of Harpagoside

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302
Precautionary Statements:P280-P305+P351+P338

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
Primary spinal cord neurons 50, 100, 200 µg/mL 24 hours To evaluate the effect of HAS on neuronal survival and axonal growth after FeSO4 injury. Results showed HAS significantly promoted neuronal survival and axonal growth at concentrations of 50-200 µg/mL. Cells. 2023 Sep 15;12(18):2281
Human primary synoviocytes (FLSs) 100 μg/mL 24 hours HPE H2O and HPE DMSO were able to enhance CB2 receptor expression and to downregulate PI-PLC β2 in synovial membranes. Nutrients. 2020 Aug 23;12(9):2545
H9C2 cells 25 μM 24 hours HAR significantly improved the viability and proliferation of H9C2 cells and alleviated DOX-induced apoptosis. Front Cell Dev Biol. 2022 Feb 10;10:813370
Osteoblast-macrophage co-culture 75 μM 3 days To assess the anti-inflammatory effect of HR in an inflammation model. Results showed that HR 75 μM significantly reduced LPS-induced IL-1β levels, indicating its anti-inflammatory properties. Nanomaterials (Basel). 2020 Sep 3;10(9):1743
Human primary synoviocytes (FLSs) 0.1 mg/mL 5 min to 48 h HPE DMSO was able to inhibit cAMP production and reduce cAMP levels even under forskolin stimulation. Pharmaceuticals (Basel). 2022 Apr 9;15(4):457
bone marrow-derived macrophages (BMMs) 50 μg/mL, 100 μg/mL, 200 μg/mL 4 days Inhibited TRAP-positive cell formation and bone resorption in a dose-dependent manner Plants (Basel). 2020 Nov 26;9(12):1656
Vero E6 cells 100 μM 6 h To evaluate the effect of Harpagoside on SARS-CoV-2 infection, results showed that Harpagoside dramatically reduced the viral RNA. Cell Metab. 2022 Mar 1;34(3):424-440. e7
HUVECs 100 μM 16 h To evaluate the effect of Harpagoside on ACE2 enzymatic activity, results showed that Harpagoside significantly elevated the enzymatic activity of ACE2. Cell Metab. 2022 Mar 1;34(3):424-440. e7
Human osteoblasts 50–100 μM 21 days To evaluate the effect of HR on osteoblast proliferation and differentiation. Results showed that HR 75 μM significantly increased osteoblast proliferation and induced the highest alkaline phosphatase (ALP) expression at days 3 and 7, indicating enhanced early osteogenic differentiation. Nanomaterials (Basel). 2020 Sep 3;10(9):1743

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Mice Diet-induced insulin-resistant mice Gavage 100 mg/kg Once daily for 4 weeks To evaluate the effect of Harpagoside on metabolic defects and viral entry, results showed that Harpagoside improved metabolic defects and inhibited viral entry. Cell Metab. 2022 Mar 1;34(3):424-440. e7
Sprague-Dawley rats Lumbar spinal stenosis (LSS) model Epidural injection 100 and 200 µg/kg Once daily for 4 weeks To evaluate the effect of epidural HAS administration on inflammatory responses and pain relief in LSS rats. Results showed HAS significantly reduced inflammatory cell infiltration, decreased iNOS expression, and downregulated pro-inflammatory cytokines. Cells. 2023 Sep 15;12(18):2281
Zebrafish DOX-induced cardiotoxicity model Water bath 25 μM Assessed after 1 day HAR significantly improved DOX-induced cardiac dysfunction and myocardial structural lesions, and reduced mitochondrial oxidative damage and restored mitophagy flux. Front Cell Dev Biol. 2022 Feb 10;10:813370

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.02mL

0.40mL

0.20mL

10.11mL

2.02mL

1.01mL

20.22mL

4.04mL

2.02mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories